JAMA Dermatology Publishes Data Showing upadacitinib Achieved Superiority Versus dupilumab for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis 3 years ago
Keane’s CarePlus Pharmacies become the First Pharmacies in Ireland to Be Accredited as Autism Friendly by AsIAm 6 years ago